Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
Showing 1 - 25 of >10,000
Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)
Recruiting
- Benign Prostatic Hyperplasia (BPH)
- REZŪM
- alpha blocker and 5-alpha reductase inhibitor
-
Aix-en-Provence, France
- +9 more
Jul 26, 2022
Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)
Recruiting
- Benign Prostatic Hyperplasia
- +7 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2022
Prostatic Hyperplasia, Prostate Hyperplasia, Prostatic Hypertrophy Trial in Seoul (alpha-blocker or 5-ARI withdrawal,
Recruiting
- Prostatic Hyperplasia
- +2 more
- alpha-blocker or 5-ARI withdrawal
- Maintenance of alpha-blocker and 5-ARI
-
Seoul, Korea, Republic ofGangnam Severance Hospital, Yonsei University College of Medicin
Aug 21, 2021
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- acapatamab
- +3 more
-
Campbell, California
- +29 more
Dec 6, 2022
Benign Prostatic Hyperplasia Trial in Seoul (combination therapy, alpha blocker monotherapy, 5 alpha reductase inhibitor
Completed
- Benign Prostatic Hyperplasia
- combination therapy
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 28, 2019
Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)
Active, not recruiting
- Prostatic Neoplasms
- Low Grade Prostate Cancer
- Dietary intervention first
- Drug (Dutasteride) intervention first
-
Quebec, Canada
- +1 more
Mar 14, 2022
Male Urogenital Diseases, Genital Diseases, Male, Prostatic Disease Trial in Hialeah (SoracteLite(TM) TPLA for BPH)
Active, not recruiting
- Male Urogenital Diseases
- +3 more
- SoracteLite(TM) TPLA for BPH
-
Hialeah, FloridaUrology Specialist Group
Jan 24, 2023
Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)
Recruiting
- Prostatic Hyperplasia
- Prostate Cancer
- Prostate hyperplasia medication
- LhRH-antagonist
-
Turku, Finland
- +1 more
Aug 17, 2023
End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)
Not yet recruiting
- End-Stage Kidney Disease
- End-Stage Renal Disease
- Metoprolol Succinate
- Carvedilol
-
Boston, Massachusetts
- +4 more
Jun 26, 2023
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Treatment of Resistant Hypertension: Cohort Study
Recruiting
- Resistant Hypertension
- Add-on therapy
-
Belgrade, Serbia
- +11 more
Oct 21, 2021
Nephrolithiasis Trial in Orange (Cialis 5Mg Tablet, Flomax 0.4Mg Capsule, Cialis + Flomax)
Enrolling by invitation
- Nephrolithiasis
- Cialis 5Mg Tablet
- +3 more
-
Orange, CaliforniaUC Irvine Health
Apr 15, 2021
Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Radionuclide Therapy
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jun 5, 2023
Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms Trial in Jackson (Prostate artery embolization)
Recruiting
- Benign Prostatic Hyperplasia (BPH)
- Lower Urinary Tract Symptoms
- Prostate artery embolization
-
Jackson, MississippiUniversity of Mississippi Medical center
Feb 22, 2022
Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)
Completed
- Rheumatoid Arthritis
- ISIS 104838
-
Birmingham, Alabama
- +30 more
Dec 1, 2022
Prostate Cancer Trial in Philadelphia (Daily adaptive SBRT with urethral sparing)
Not yet recruiting
- Prostate Cancer
- Daily adaptive SBRT with urethral sparing
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Mar 26, 2023
Renal Stone Trial in Lahore (Extracorporeal shock wave lithotripsy, Extracorporeal Shock Wave Lithotripsy combined with
Completed
- Renal Stone
- Extracorporeal shock wave lithotripsy
- Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy.
-
Lahore, Punjab, Pakistanservices Institute of Medical Sciences
Feb 10, 2023
Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- (no location specified)
Jul 28, 2023
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)
Not yet recruiting
- Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
- Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 13, 2022
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Screening for Alpha Thalassemia in Healthy Volunteers
Recruiting
- Alpha Thalassemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))
Not yet recruiting
- Pompe Disease
- +7 more
- Multi-ingredient supplement (PDT-MIS)
- Placebo (PLA)
- (no location specified)
Nov 8, 2023